Study of Anal Cytologies in Patients With High Grade Cervical Intraepithelial Neoplasia (CIN II and III)
Anal Carcinoma, Anal Condyloma
About this trial
This is an interventional prevention trial for Anal Carcinoma
Eligibility Criteria
Inclusion Criteria:
Female patients aged 18-65 years with an anatomic pathology compatible with CIN II / CIN III, without restriction regarding skin color, race, ethnicity, religion; Patients of the Oncology Gynecology Service of the HCSL, registered in the hospital management system, in outpatient consultations; Those who agree to participate in the study and sign the ICF. Patients attended at the general gynecological surgery outpatient clinic (control group) with no evidence of colpocitological alteration.
-
Exclusion Criteria:
Patients who withdraw the consent term. History of previous anal cancer / anal intraepithelial neoplasia. Immunosuppressed: HIV, SLE, users of immunosuppressive and transplanted drugs.
-
Sites / Locations
- Lyliana C R BarbosaRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
No Intervention
No Intervention
No Intervention
Active Comparator
Control Group with conventional citology
Control Group with liquid based citology
CIN 2-3/Conventional Citology
CIN 2-3/Liquid Based
Patients who do not have high grade cervical intraepithelial neoplasia and will have anal cytology performed by conventional method
Patients who do not have cervical intraepithelial neoplasia of high grade and will have anal cytology performed by liquid based method
Patients with high grade cervical intraepithelial neoplasia and will have anal citology performed by conventional method
Patients with high grade cervical intraepithelial neoplasia and will have anal citology performed by liquid based method